How it works
How Much Does Stereotaxic radiosurgery Cost in China?
Stereotaxic radiosurgery in China typically costs from $10,800 to $12,500. The total expense depends on the chosen technology, the number of sessions, and the hospital tier in cities like Beijing, Shanghai, or Chengdu. Patients save around 61% compared to the United States, where the average price is $30,000. Standard medical packages in China generally include specialized oncology consultations, high-resolution imaging, and the radiosurgery procedure itself.
- Gamma Knife: Adds a specialized focus for intracranial lesions and is often more affordable.
- CyberKnife: Typically adds 10-20% to the cost for robotic flexibility in treating body tumors.
- Fractionated treatment: Costs more than single-session radiosurgery due to multiple hospital visits and doses.
- Diagnostic imaging: Pre-treatment scans like PET/CT or high-resolution MRI add approximately 15% to bills.
Bookimed Expert Insight: Choosing JCI-accredited facilities like Hainan Chengmei Hospital or Fosun Health ensures international safety standards. Expert physicians in China, such as Dr. Yang Jun who has performed over 6,000 CyberKnife procedures, offer immense clinical experience. High-end patient wards and 5G-supported remote consultations add significant value for international patients. While prices in tier-1 cities are higher, these centers house world-class equipment like the Philips Ingenia Elition 3.0T MRI.
| China | Turkey | Austria | |
|---|---|---|---|
| Stereotaxic radiosurgery | from $10,800 | from $4,500 | ≈ $9,500 |
Discover the Best Stereotaxic radiosurgery Clinics in China: 5 Verified Options and Prices
Shanghai Tongji Hospital, International Department
Stereotaxic radiosurgery Overview in China
- Radiotherapy - from $8,000This therapy uses high-energy waves to destroy cancer cells, providing a non-surgical treatment with few side effects.
- Stereotaxic radiosurgery - from $10,800This therapy targets tumors with precise radiation, avoiding damage to surrounding tissues.
- Radiation therapy for brain tumor - from $6,700This therapy aims to destroy brain tumors using high-energy rays, reducing symptoms and improving survival rates.
- Radiotherapy for prostate cancer - from $10,000This therapy targets prostate tumors with radiation, annihilating cancer cells while preserving healthy tissue.
- Radiotherapy for lung cancer - from $7,000This therapy aims to kill cancer cells in the lungs using high-energy x-rays.
Day 1
- Arrival in the country.
- Transfer to the hotel from the airport.
Day 2
- Transfer from hotel to clinic.
- Consultation with specialists.
- Complete blood count with cancer markers test.
- Proteinogram test.
Day 3
- Preparation for Stereotaxic radiosurgery.
- Procedure specifics explained.
Day 4
- Stereotaxic radiosurgery procedure, lasts 1-4 hours.
- Local anesthesia is used.
- Transfer back to the hotel after the procedure.
Day 5-7
- Rest and recovery at the hotel.
- Language assistance provided for non-native speakers.
Week 2
- Follow-up consultation with specialists.
- Patient is discharged.
- Transfer to the airport.
Please note that this is a general guide and individual cases may vary.
- Bookimed deposit: $200 or €200.
- Clinic deposit: Pay a set percentage in advance.
Our Trusted Doctors
View all Doctors
Liao Zhengyin
Chief physician and professor. Grade 1 Expert at the Cancer Center, West China Hospital, Sichuan University (ranked No. 2 in China). Completed a postdoctoral fellowship in interventional radiology at the Chinese PLA General Hospital. Leads multidisciplinary team (MDT) care for complex tumors. Expert in minimally invasive interventional oncology for liver, lung, and pancreatic cancers.
Accreditations: Council Member, WATA. Member of CACA and CMDA committees on intervention, ablation, radioactive seeds, and pain. In 2023, inaugural director member, Palliative Care Committee, Sichuan MDA. Editorial board member of the Chinese Journal of Interventional Imaging and Therapy. Editorial board member of the Chinese Journal of Pain Medicine.
Leads 2 provincial S&T projects and 2 NSFC projects. Has 40+ papers, with 30+ as first or corresponding author. Highest impact factor: 10.73. Hepatocellular carcinoma (HCC) cohort: TACE + lenvatinib vs TACE + sorafenib. OS 18.97 vs 10.77 months. PFS 10.6 vs 5.4 months. ORR 66.8% vs 33.3%.

Luo Xiaoping
Professor Luo Xiaoping is a nationally recognized interventional radiologist and a leading authority in Western China. He began pioneering vascular interventions in the early 1990s. He helped found the Interventional Group at the Second Affiliated Hospital of Chongqing Medical University.
He has completed over 100,000 interventional procedures, including about 4,000 complex cases. His key skills include TACE for hepatocellular carcinoma, Budd–Chiari interventions, TIPS, and single-stage bilateral stenting for hilar biliary obstruction, with success rates near 100%. He has been a master’s supervisor since 2007. He has trained many physicians, guided complex cases at more than 40 major hospitals across Western China, and helped build interventional programs. He has published 32 papers as first or corresponding author (22 CSCD core, 4 Chinese core, 6 CSCD extended).

Sun Chen Yang
Professor Sun Chen Yang combines traditional Chinese medicine with modern neurosurgery at Eber Perennial Brain Hospital.
- Director of the Institute of Integrative Traditional Chinese and Western Medicine at Peking University
- Head of Department of Integrative Traditional Chinese and Western Medicine at Peking University First Hospital
- Author of over 100 articles in SCI and other journals
- Consulting expert for the Central Commission for Health and Talents of Traditional Chinese Medicine in Beijing

He Weibing
Dr. He Weibing is a pioneer of argon-helium cryoablation in China with more than 20 years of frontline practice. He was a founding member of Fuda Cancer Hospital (Guangzhou). He co-founded its Minimally Invasive Tumor Treatment Center and served as Executive Deputy Director. He also helped found the Ablation Group of the China Anti-Cancer Association. He has been the primary operator in more than 10,000 procedures.
He specializes in tumor cryoablation and is proficient in 125I seed brachytherapy, with a focus on liver and lung cancers. He proposed ten argon-helium techniques. Key co-authored data include: lung cryotherapy n=508; NSCLC n=120 (CR 25.5%, PR 41.8%, 6/12/24-month survival 64%/55%/36%); pancreatic cancer n=38 (median survival 12 months). He served on editorial boards in 2008 and 2010. He has been a national trainer for Varian and Boston Scientific since 2001.
Video Stories from Bookimed Patients
Share this content
Anna Leonova
Fast Facts about Stereotaxic radiosurgery

Stereotaxic Radiosurgery
It is a non-invasive radiation treatment that precisely targets tumors and abnormalities in the brain and other parts of the body.





